Sea You at Fetch Long Beach
|Articles|November 27, 2008

2 firms partner for canine cancer detection

Raleigh, N.C. -- A formal partnership was announced between PharmaCom BioVet Inc. and the United Kingdom's PetScreen, a company that specializes in early cancer detection in canines.

Raleigh, N.C.

-- A formal partnership was announced between PharmaCom BioVet Inc. and the United Kingdom's PetScreen, a company that specializes in early cancer detection in canines.

The partnership aims to improve cancer diagnosis and treatment for dogs, with both companies working under the premise that early detection is key.

They began focusing efforts on canine cancer after executives at both firms lost a pet to cancer.

PetScreen developed new canine cancer detection methods and PharmaCom announced a plan to open cancer treatment centers across the country.


Related to this article

Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.
Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.